Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Zimmer Biomet Holdings Inc (NYSE:ZBH)

120.66
Delayed Data
As of Mar 24
 +0.26 / +0.22%
Today’s Change
95.63
Today|||52-Week Range
133.21
+16.92%
Year-to-Date
ZBH Regular Dividend: ZBH will begin trading ex-dividend on 03/29/17 with a $0.24 dividend payable to shareholders of record as of 03/31/17.
Is Zimmer Biomet (ZBH) a Great Stock for Value Investors?
Mar 23 / Zacks.com - Paid Partner Content
4 Health Care Charts Signaling Buys: Pfizer, Amgen Included
Mar 21 / TheStreet.com - Paid Partner Content
MedTech Long-Term Prospects Impress: Which Stocks to Buy?
Mar 22 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close120.40
Today’s open120.40
Day’s range120.31 - 121.11
Volume716,485
Average volume (3 months)1,500,690
Market cap$24.3B
Dividend yield0.80%
Data as of 4:01pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+96.10%
Earnings growth (this year)+7.92%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+28.11%
P/E ratio79.9
Price/Sales2.72
Price/Book2.50

Competitors

 Today’s
change
Today’s
% change
BCRC R Bard Inc+1.18+0.47%
BSXBoston Scientific Co...+0.07+0.29%
BDXBecton Dickinson and...+0.16+0.09%
TFXTeleflex Inc+0.08+0.04%
Data as of 4:05pm ET, 03/24/2017

Financials

Next reporting dateApril 27, 2017
EPS forecast (this quarter)$2.11
Annual revenue (last year)$7.7B
Annual profit (last year)$305.9M
Net profit margin3.98%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
David C. Dvorak
Chief Financial Officer &
Senior Vice President
Daniel P. Florin
Corporate headquarters
Warsaw, Indiana

Forecasts


Search for Jobs